Literature DB >> 16772345

Visceral adiposity and endothelial lipase.

Marie-Eve Paradis1, Karen O Badellino, Daniel J Rader, André Tchernof, Christian Richard, Van Luu-The, Yves Deshaies, Jean Bergeron, Wiedad R Archer, Patrick Couture, Nathalie Bergeron, Benoît Lamarche.   

Abstract

CONTEXT: Overexpression of endothelial lipase (EL) has been shown to reduce plasma high-density lipoprotein cholesterol levels in animal models. However, the extent to which EL contributes to modulate the deteriorated high-density lipoprotein profile observed in obesity in humans is less clear.
OBJECTIVES: The objectives of this study were to investigate the association between levels of obesity and visceral adiposity in particular and plasma EL concentrations.
METHODS: Postheparin plasma EL concentrations were measured by ELISA and visceral adiposity by computed tomography in a sample of 80 sedentary men in good health. EL mRNA levels in abdominal sc and omental adipose tissues obtained during abdominal hysterectomies were measured in another sample of 14 women.
RESULTS: Plasma EL levels were positively correlated with body mass index (R = 0.46, P < 0.0001), visceral adipose tissue accumulation (R = 0.44, P < 0.0001), and a proatherogenic lipid profile including increased plasma cholesterol and triglycerides. However, EL mRNA levels were similar in sc and omental AT and were 10,000-fold lower than lipoprotein lipase mRNA levels in those tissues.
CONCLUSIONS: Increased visceral adiposity is significantly correlated with elevated plasma EL levels, but this association is unlikely to be causal and may reflect other common metabolic alterations.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16772345     DOI: 10.1210/jc.2006-0766

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  12 in total

1.  Role of SN1 lipases on plasma lipids in metabolic syndrome and obesity.

Authors:  Verónica Miksztowicz; Laura Schreier; Mary McCoy; Diego Lucero; Eduardo Fassio; Jeffrey Billheimer; Daniel J Rader; Gabriela Berg
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-01-23       Impact factor: 8.311

2.  Mechanisms of lipase maturation.

Authors:  Mark H Doolittle; Miklós Péterfy
Journal:  Clin Lipidol       Date:  2010-02-01

3.  Increased Hepatic Expression of Endothelial Lipase Inhibits Cholesterol Diet-Induced Hypercholesterolemia and Atherosclerosis in Transgenic Rabbits.

Authors:  Chuan Wang; Kazutoshi Nishijima; Shuji Kitajima; Manabu Niimi; Haizhao Yan; Yajie Chen; Bo Ning; Fumikazu Matsuhisa; Enqi Liu; Jifeng Zhang; Y Eugene Chen; Jianglin Fan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-05-25       Impact factor: 8.311

4.  A novel fluorogenic substrate for the measurement of endothelial lipase activity.

Authors:  Andrew L Darrow; Matthew W Olson; Hong Xin; Sharon L Burke; Charles Smith; Celine Schalk-Hihi; Robyn Williams; Shariff S Bayoumy; Ingrid C Deckman; Matthew J Todd; Bruce P Damiano; Margery A Connelly
Journal:  J Lipid Res       Date:  2011-02       Impact factor: 5.922

5.  Endothelial lipase is localized to follicular epithelial cells in the thyroid gland and is moderately expressed in adipocytes.

Authors:  Margery A Connelly; Michael R D'Andrea; Jenson Qi; Keli C Dzordzorme; Bruce P Damiano
Journal:  J Histochem Cytochem       Date:  2012-06-26       Impact factor: 2.479

6.  Effect of weight loss, independent of change in diet composition, on apolipoprotein AI kinetic in men with metabolic syndrome.

Authors:  Caroline Richard; Patrick Couture; Sophie Desroches; Alice H Lichtenstein; Benoît Lamarche
Journal:  J Lipid Res       Date:  2012-11-02       Impact factor: 5.922

7.  The T111I variant in the endothelial lipase gene and risk of coronary heart disease in three independent populations.

Authors:  Majken K Jensen; Eric B Rimm; Kenneth J Mukamal; Andrew C Edmondson; Daniel J Rader; Ulla Vogel; Anne Tjønneland; Thorkild I A Sørensen; Erik B Schmidt; Kim Overvad
Journal:  Eur Heart J       Date:  2009-05-02       Impact factor: 29.983

8.  Dyslipidaemia of obesity, metabolic syndrome and type 2 diabetes mellitus: the case for residual risk reduction after statin treatment.

Authors:  Vasilios G Athyros; Konstantinos Tziomalos; Asterios Karagiannis; Dimitri P Mikhailidis
Journal:  Open Cardiovasc Med J       Date:  2011-02-24

9.  Endothelial lipase and reverse cholesterol transport in type 2 diabetes mellitus.

Authors:  Sammy Wm Shiu; Huali Zhou; Ying Wong; Kathryn Cb Tan
Journal:  J Diabetes Investig       Date:  2010-06-01       Impact factor: 4.232

Review 10.  Lipoprotein subfractions in metabolic syndrome and obesity: clinical significance and therapeutic approaches.

Authors:  Dragana Nikolic; Niki Katsiki; Giuseppe Montalto; Esma R Isenovic; Dimitri P Mikhailidis; Manfredi Rizzo
Journal:  Nutrients       Date:  2013-03-18       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.